The ESMO Deep Dive - Lower Digestive Cancers Webinar Series recordings and slides are available to all ESMO Members.
ESMO Deep Dive: Lower Digestive Cancers - Understanding the Biology and Optimising Therapeutic Strategies for Patients with Anal Cancer
It is with great pleasure that I invite you to participate in the ESMO webinar on Deep Dive into Lower Digestive Cancers that will elaborate on the biology and therapeutic strategies for patients with anal cancer.
This webinar is developed with the aim to acquire a deeper understanding of the clinical course of malignant disease of the lower digestive system and understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for lower digestive cancers. Furthermore, the programme will enhance development of skills and abilities for critical analysis, interpretation of research data and therapeutic strategies, as well as becoming better equipped for informed, innovative thinking and engagement in ongoing or new research projects.
I am delighted to announce the distinguished speakers who will join me in this webinar. We will firstly discuss localised anal cancer and what is the best curative protocol and future research directions. The next lecture will focus on biologic and biomarker guidance in the management of patients with metastatic anal squamous cancer, discussing optimal regimens, combinations and sequencing. We will then finish the lectures with a discussion on insights in recurrent or advanced anal squamous cancer: focusing on the case for immunotherapy and forthcoming therapeutic options. The lectures will then be followed by a live discussion by the speaker’s panel.
The programme is designed to provide an overview of the state of the art and ongoing research in therapies for patients with anal cancer. It will offer expert opinion exchange and provide some important considerations for practice and research in this field. I strongly encourage and invite you to register and join us all in this new ESMO activity.
Dr. Robert Glynne-Jones
Mount Vernon Cancer Centre, Northwood, UK
Speakers
Programme
Time |
Title |
Speaker |
---|---|---|
5 min |
Welcome and Introduction |
Robert Glynne-Jones |
25 min |
Localised Anal Cancer: What is the best Curative Protocol and Future Research Directions |
Sebastian Stintzing |
25 min |
Biologic and Biomarker Guidance in the Management of Patients with Metastatic Anal Squamous Cancer: Optimal Regimens, Combinations and Sequencing |
Stefano Kim |
25 min |
Research Insights in Recurrent or Advanced Anal Squamous Cancer: the Case for Immunotherapy and Forthcoming Therapeutic Options |
Sara Lonardi |
15 min |
LIVE Q&A |
All |
A certificate of attendance and 2 ESMO-MORA category 1 points will be awarded for live attendance at this event
Learning objectives:
- To acquire a deeper understanding of the clinical course of malignant disease of the lower digestive system
- To understand biological hypotheses on classification and risk stratification, ongoing/required research in therapeutics and knowledge of use of omics technologies for biomarker-enabled precision medicine for Lower Digestive Cancers
- To develop skills and abilities for critical analysis, interpretation of research data and therapeutic strategies
- To become better equipped for informed, innovative thinking and engagement in ongoing or new research projects